<VariationArchive VariationID="632520" VariationName="NM_000349.3(STAR):c.125dup (p.Thr44fs)" VariationType="Duplication" Accession="VCV000632520" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2019-05-27" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="620299" VariationID="632520">
      <GeneList>
        <Gene Symbol="STAR" FullName="steroidogenic acute regulatory protein" GeneID="6770" HGNC_ID="HGNC:11359" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="38142700" stop="38150952" display_start="38142700" display_stop="38150952" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="38000217" stop="38008599" display_start="38000217" display_stop="38008599" Strand="-" />
          </Location>
          <OMIM>600617</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000349.3(STAR):c.125dup (p.Thr44fs)</Name>
      <CanonicalSPDI>NC_000008.11:38148693:CCCCCC:CCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8p11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="38148693" stop="38148694" display_start="38148693" display_stop="38148694" variantLength="1" positionVCF="38148693" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="38006211" stop="38006212" display_start="38006211" display_stop="38006212" variantLength="1" positionVCF="38006211" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>T44fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.38006217dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.38006217dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.38148699dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.38148699dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011827.1" sequenceAccession="NG_011827" sequenceVersion="1" change="g.7389dup">
            <Expression>NG_011827.1:g.7389dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000349.3" sequenceAccession="NM_000349" sequenceVersion="3" change="c.125dup" MANESelect="true">
            <Expression>NM_000349.3:c.125dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000340.2" sequenceAccession="NP_000340" sequenceVersion="2" change="p.Thr44fs">
            <Expression>NP_000340.2:p.Thr44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000349.2" sequenceAccession="NM_000349" sequenceVersion="2" change="c.125dupG">
            <Expression>NM_000349.2:c.125dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="750549499" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000349.3(STAR):c.125dup (p.Thr44fs) AND Congenital lipoid adrenal hyperplasia due to STAR deficency" Accession="RCV000779556" Version="5">
        <ClassifiedConditionList TraitSetID="2477">
          <ClassifiedCondition DB="MedGen" ID="C0342474">Congenital lipoid adrenal hyperplasia due to STAR deficency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-05-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000349.3(STAR):c.125dup (p.Thr44fs) AND not provided" Accession="RCV000792850" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-09-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-09-24" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-05-27" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10700722</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21647419</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8948562</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9097960</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2477" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2693" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lipoid adrenal hyperplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital lipoid adrenal hyperplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lipoid CAH</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lipoid hyperplasia congenital of adrenal cortex with male pseudohermaphroditism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cholesterol monooxygenase (side-chain cleaving) deficiency</ElementValue>
                <XRef ID="Cholesterol+monooxygenase+%28side-chain+cleaving%29+deficiency/7970" DB="Genetic Alliance" />
                <XRef ID="44231009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital lipoid adrenal hyperplasia due to STAR deficency</ElementValue>
                <XRef ID="MONDO:0008725" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPERPLASIA I</ElementValue>
                <XRef Type="MIM" ID="201710" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LCAH</ElementValue>
                <XRef Type="MIM" ID="201710" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Lipoid congenital adrenal hyperplasia, the most severe disorder of steroid hormone biosynthesis, is caused by a defect in the conversion of cholesterol to pregnenolone, the first step in adrenal and gonadal steroidogenesis. All affected individuals are phenotypic females with a severe salt-losing syndrome that is fatal if not treated in early infancy (summary by Lin et al., 1991 and Bose et al., 1996).</Attribute>
                <XRef Type="MIM" ID="201710" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1465" />
                <XRef ID="1465" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="418" DB="Orphanet" />
              <XRef ID="90790" DB="Orphanet" />
              <XRef ID="C0342474" DB="MedGen" />
              <XRef ID="MONDO:0008725" DB="MONDO" />
              <XRef Type="MIM" ID="201710" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1791308" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="1301538" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000916229" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21647419</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10700722</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9097960</ID>
          </Citation>
          <Comment>The STAR c.125dupG (p.Thr44HisfsTer3) variant results in a frameshift and is predicted to result in premature termination of the protein. The p.Thr44HisfsTer3 variant has been reported in three studies and is found in a total of seven patients with congenital adrenal hyperplasia (CAH), including in one in a homozygous state, in five (including one sibling pair) in a compound heterozygous state and in one in a heterozygous state in whom a second allele was not detected (Nakae et al. 1997; Shima et al. 2000; FlÃ¼ck et al. 2011). All seven patients were diagnosed with lipoid CAH. The p.Thr44HisfsTer3 variant was also found in the unaffected father of the sibling pair in a heterozygous state (FlÃ¼ck et al. 2011). Control data are unavailable for the p.Thr44HisfsTer3 variant, which is reported at a frequency of 0.000058 in the East Asian population of the Genome Aggregation Database but this is based on one allele in a region of good sequence coverage so the variant is presumed to be rare. Expression analysis in COS-1 cells demonstrated that the p.Thr44HisfsTer3 variant protein had a pregnenolone production rate comparable to the vector control and is therefore described as completely inactive (FlÃ¼ck et al. 2011). Based on the evidence from the literature and the potential impact of frameshift variants, the p.Thr44HisfsTer3 variant is classified as pathogenic for congenital adrenal hyperplasia, and has most often been reported in patients with the lipoid subtype. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="STAR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="8" alternateAllele="GC" referenceAllele="G" start="38006211" stop="38006211" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000349.2:c.125dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201710" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1825949" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4875121|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000932174" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8948562</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21647419</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in STAR are known to be pathogenic (PMID: 8948562). This variant has been observed to segregate with lipoid adrenal hyperplasia in a family (PMID: 21647419) and has been observed in individuals with¬†lipoid adrenal hyperplasia (PMID:¬†9097960, 10700722). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This sequence change creates a premature translational stop signal (p.Thr44Hisfs*3) in the STAR gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="STAR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.38006211_38006212insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1825949" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1791308" TraitType="Disease" MappingType="XRef" MappingValue="201710" MappingRef="OMIM">
        <MedGen CUI="C0342474" Name="Congenital lipoid adrenal hyperplasia due to STAR deficency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

